Efficiency of Umbilical Cord Blood Cells in Patients with Treatment-Resistant Depressions


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

We studied the efficacy of umbilical cord blood cells in the therapy of treatment-resistant depressive states in women. Concentrated umbilical cord blood cells were administered in a dose of 250 millions cells (4 injections at 1-week intervals). The control group received placebo. In both groups, reduction of depressive disorders and the decrease in hypothymia severity were observed. Infusions of cell concentrate contributed to delayed correction of treatment resistance and reduced the severity of depression to moderate. In the main group, significant, persistent, and long-term positive dynamics was observed in the cognitive sphere. The therapeutic potential of umbilical cord blood cell concentrate can be used to overcome treatment resistance formed in depressive patients.

Об авторах

A. Smulevich

Research Center of Mental Health, Russian Academy of Medical Sciences

Email: yanamorozova0@gmail.com
Россия, Moscow

E. Dubnitskaya

Research Center of Mental Health, Russian Academy of Medical Sciences

Email: yanamorozova0@gmail.com
Россия, Moscow

E. Voronova

Research Center of Mental Health, Russian Academy of Medical Sciences

Email: yanamorozova0@gmail.com
Россия, Moscow

Ya. Morozova

Russian Cardiology Research-and-Production Complex, Ministry of Health of the Russian Federation

Автор, ответственный за переписку.
Email: yanamorozova0@gmail.com
Россия, Moscow

S. Radaev

CryoCenter Umbilical Cord Blood Bank

Email: yanamorozova0@gmail.com
Россия, Moscow


© Springer Science+Business Media New York, 2016

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах